| | ATN | ADQI | Pannu | KDIGO | Bucaloiu |
|---|
| Age (every one year added) | 1.046 (1.033–1.060) | 1.050 (1.037–1.063) | 1.050 (1.036–1.064) | 1.043 (1.030–1.057) | 1.052 (1.038–1.066) |
| NYHA III-IV (Y/N) | 1.437 (1.055–1.957) | 1.557 (1.147–2.115) | 1.675 (1.234–2.275) | 1.641 (1.206–2.232) | 1.626 (1.198–2.208) |
| Diabetes (Y/N) | 4.240 (3.175–5.662) | 4.043 (3.039–5.379) | 3.890 (2.923–5.176) | 4.338 (3.252–5.788) | 4.035 (3.035–5.364) |
| RRT (Y/N) | 5.363 (3.487–8.248) | 6.145 (4.009–9.419) | 9.555 (6.317–14.453) | 9.446 (6.226–14.33) | 11.018 (7.314–15.599) |
| no AKI (reference) |
| AKI with complete recovery | 1.69 (1.20–2.38)* | 1.45 (1.03–2.04)* | 1.17 (0.79–1.74) | 1.37 (0.95–1.99) | 1.37 (0.91–2.08) |
| AKI with partial recovery | 15.25 (10.68–21.78)* | 11.39 (8.09–16.02)* | 4.82 (3.51–6.62)* | 5.60 (4.01–7.81)* | 3.62 (2.64–4.95)* |
- *P < 0.05
- ADQI: Acute Dialysis Quality Initiative; AKI: acute kidney injury; ATN: Acute Renal Failure Trial Network; BMI: Body mass index; KDIGO: Kidney Disease: Improving Global Outcomes; MAE: major adverse events; NYHA: New York heart association; RRT: Renal replacement therapy
